BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/31/2024 7:21:20 AM | Browse: 37 | Download: 143
 |
Received |
|
2024-06-19 13:15 |
|
Peer-Review Started |
|
2024-06-19 13:15 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-27 09:49 |
|
Revised |
|
2024-09-28 00:02 |
|
Second Decision |
|
2024-10-21 02:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-21 10:57 |
|
Articles in Press |
|
2024-10-21 10:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-23 01:08 |
|
Publish the Manuscript Online |
|
2024-10-31 07:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Minireviews |
| Article Title |
Oral blood pressure augmenting agents for intravenous vasopressor weaning
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
John C Robinson, Mariam ElSaban, Nathan J Smischney and Patrick M Wieruszewski |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Patrick M Wieruszewski, Assistant Professor, Department of Anesthesiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. wieruszewski.patrick@mayo.edu |
| Key Words |
Vasopressor; Shock; Hypotension; Midodrine; Droxidopa; Atomoxetine; Pseudoephedrine |
| Core Tip |
This paper sets to explore the evolving role of oral blood pressure augmenting agents in the intensive care setting. With their ability to increase blood pressure through direct or indirect vasoconstriction, these agents have been increasingly utilized to facilitate weaning from intravenous (IV) vasopressors. Use of these agents may have a role in reducing IV vasopressor exposure, intensive care unit lengths of stay, and overall healthcare resource utilization. Despite being commonly used, their role in practice should be tempered by lack of demonstrable efficacy in major trials and important adverse effect considerations. |
| Publish Date |
2024-10-31 07:21 |
| Citation |
<p>Robinson JC, ElSaban M, Smischney NJ, Wieruszewski PM. Oral blood pressure augmenting agents for intravenous vasopressor weaning. <i>World J Clin Cases</i> 2024; 12(36): 6892-6904</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i36/6892.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i36.6892 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
